See more : Alfen N.V. (ALFEN.AS) Income Statement Analysis – Financial Results
Complete financial analysis of Inovalon Holdings, Inc. (INOV) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Inovalon Holdings, Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- Ceconomy AG (CEC.DE) Income Statement Analysis – Financial Results
- Softline Holding PLC (SFTL.IL) Income Statement Analysis – Financial Results
- PT Lenox Pasifik Investama Tbk (LPPS.JK) Income Statement Analysis – Financial Results
- DVS Technology AG (DIS.DE) Income Statement Analysis – Financial Results
- Greenway Greenhouse Cannabis Corporation (GWAY.CN) Income Statement Analysis – Financial Results
Inovalon Holdings, Inc. (INOV)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: http://www.inovalon.com
About Inovalon Holdings, Inc.
Inovalon Holdings, Inc. provides cloud-based platforms for data-driven healthcare. It operates Inovalon ONE Platform, a cloud-based platform that interconnect with the healthcare ecosystem to aggregate and analyze data in real-time, as well as empowers the application in resulting insights. The company also operates myABILITY software platform, an integrated set of cloud-based applications for providers that offers connectivity, administrative, clinical and quality analysis, management, and performance improvement capabilities to acute, post-acute, and ambulatory point-of-care provider facilities. In addition, it offers advisory, implementation, and support services. The company serves health plans and provider organizations, as well as pharmaceutical, medical device, and diagnostics companies. Its platforms include information of data pertaining to approximately 988,000 physicians; 522,000 clinical facilities; and approximately 314 million individuals and 53 billion medical events. Inovalon Holdings, Inc. was founded in 1998 and is headquartered in Bowie, Maryland.
| Metric | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 667.52M | 642.41M | 527.68M | 449.36M | 427.59M | 437.27M | 361.54M | 295.80M | 300.28M | 239.69M |
| Cost of Revenue | 167.82M | 167.81M | 144.83M | 151.05M | 159.17M | 146.14M | 112.76M | 120.05M | 101.19M | 102.70M |
| Gross Profit | 499.70M | 474.60M | 382.85M | 298.31M | 268.42M | 291.13M | 248.78M | 175.74M | 199.09M | 136.99M |
| Gross Profit Ratio | 74.86% | 73.88% | 72.55% | 66.39% | 62.78% | 66.58% | 68.81% | 59.41% | 66.30% | 57.15% |
| Research & Development | 33.50M | 33.69M | 28.64M | 27.38M | 29.15M | 22.33M | 23.13M | 21.19M | 15.50M | 14.86M |
| General & Administrative | 216.62M | 200.76M | 205.04M | 149.95M | 137.28M | 115.03M | 88.57M | 80.64M | 72.66M | 63.18M |
| Selling & Marketing | 62.94M | 62.41M | 45.53M | 34.10M | 27.08M | 14.68M | 7.14M | 5.95M | 6.79M | 6.75M |
| SG&A | 279.56M | 263.17M | 250.57M | 184.05M | 164.35M | 129.71M | 95.71M | 86.59M | 79.45M | 69.94M |
| Other Expenses | 114.93M | 108.25M | 96.73M | 53.09M | 37.28M | 22.63M | 19.88M | 15.52M | 12.90M | 11.23M |
| Operating Expenses | 427.99M | 405.11M | 375.94M | 264.52M | 230.79M | 174.68M | 138.72M | 123.30M | 107.85M | 96.02M |
| Cost & Expenses | 595.81M | 572.92M | 520.76M | 415.57M | 389.95M | 320.82M | 251.48M | 243.35M | 209.04M | 198.72M |
| Interest Income | 479.00K | 2.24M | 2.18M | 5.43M | 5.79M | 3.00M | 6.00K | 9.00K | 11.00K | 10.00K |
| Interest Expense | 56.18M | 65.83M | 50.90M | 6.23M | 5.07M | 4.42M | 1.34M | 79.00K | 129.00K | 62.00K |
| Depreciation & Amortization | 114.93M | 108.25M | 96.73M | 53.09M | 37.28M | 22.63M | 19.88M | 15.52M | 12.90M | 11.23M |
| EBITDA | 186.56M | 179.96M | 94.07M | 91.90M | 81.25M | 141.76M | 129.95M | 67.97M | 104.15M | 52.21M |
| EBITDA Ratio | 27.95% | 28.01% | 17.83% | 20.45% | 19.00% | 32.42% | 35.94% | 22.98% | 34.68% | 21.78% |
| Operating Income | 71.71M | 69.49M | 6.92M | 33.79M | 37.63M | 116.46M | 110.06M | 52.45M | 91.24M | 40.97M |
| Operating Income Ratio | 10.74% | 10.82% | 1.31% | 7.52% | 8.80% | 26.63% | 30.44% | 17.73% | 30.38% | 17.09% |
| Total Other Income/Expenses | -56.25M | -63.61M | -60.47M | -1.20M | 1.27M | -1.75M | -1.33M | -70.00K | -118.00K | -52.00K |
| Income Before Tax | 15.46M | 5.88M | -53.56M | 32.59M | 38.90M | 114.71M | 108.73M | 52.38M | 91.12M | 40.92M |
| Income Before Tax Ratio | 2.32% | 0.91% | -10.15% | 7.25% | 9.10% | 26.23% | 30.07% | 17.71% | 30.34% | 17.07% |
| Income Tax Expense | -7.12M | -1.90M | -14.39M | -2.23M | 11.80M | 48.65M | 43.38M | 19.66M | 35.96M | 15.99M |
| Net Income | 22.58M | 7.78M | -39.16M | 34.82M | 27.10M | 66.06M | 65.35M | 32.72M | 55.16M | 24.93M |
| Net Income Ratio | 3.38% | 1.21% | -7.42% | 7.75% | 6.34% | 15.11% | 18.08% | 11.06% | 18.37% | 10.40% |
| EPS | 0.15 | 0.05 | -0.27 | 0.24 | 0.18 | 0.45 | 0.53 | 1.47 | 2.48 | 1.12 |
| EPS Diluted | 0.15 | 0.05 | -0.27 | 0.24 | 0.18 | 0.45 | 0.53 | 1.47 | 2.48 | 1.12 |
| Weighted Avg Shares Out | 149.72M | 148.63M | 145.39M | 142.23M | 150.05M | 145.75M | 122.26M | 22.22M | 22.22M | 22.22M |
| Weighted Avg Shares Out (Dil) | 149.72M | 148.63M | 145.39M | 142.74M | 150.96M | 148.28M | 122.26M | 22.22M | 22.22M | 22.22M |
Coastal Investment Advisors Inc. Makes New $270,000 Investment in Inovalon Holdings Inc (NASDAQ:INOV)
Vaccine Hopes Help Dow Reach Fourth Day of Gains
Invesco Ltd. Raises Position in Inovalon Holdings Inc (NASDAQ:INOV)
Geode Capital Management LLC Has $19.71 Million Stock Position in Inovalon Holdings Inc (NASDAQ:INOV)
Nuveen Asset Management LLC Boosts Stock Position in Inovalon Holdings Inc (NASDAQ:INOV)
Inovalon Sees Unusually Large Options Volume (NASDAQ:INOV)
Inovalon ONE® Platform Selected by Cardinal Health
Inovalon ONE® Platform Selected by Cardinal Health
Priority Health Selects The Inovalon ONE® Platform
Source: https://incomestatements.info
Category: Stock Reports